Immunovant, Inc. (IMVT)
26.60
+0.24
(+0.91%)
USD |
NASDAQ |
Feb 20, 16:00
26.60
0.00 (0.00%)
After-Hours: 20:00
Immunovant SG&A Expense (Quarterly) : 15.44M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Boston Scientific Corp. | 1.834B |
| Viridian Therapeutics, Inc. | 24.32M |
| Plus Therapeutics, Inc. | 3.443M |
| Nutriband, Inc. | 3.492M |
| Definium Therapeutics, Inc. | 14.69M |